Bruxelles ouvre le débat sur les cellules souches
Le groupe européen consultatif sur les sciences de la vie encourage la création d’un registre européen de cellules souches.
Marie-Martine Buckens
- ABB LTD N45.420.82%
- ALCON N80.120.7%
- RICHEMONT N144.3-0.35%
- GEBERIT N593.41.3%
- GIVAUDAN N40190.5%
- HOLCIM N94.60.62%
- KUEHNE+NAGEL INT N179.65-2.26%
- LOGITECH N67.643.05%
- LONZA N576.20.88%
- NESTLE N87.610.63%
- NOVARTIS N91.450.37%
- PARTNERS GROUP N11151.5%
- ROCHE GS260.90.39%
- SIKA N208.51.07%
- SONOVA HOLDING AG253.50%
- SWISS LIFE HOLDING AG N840.80.12%
- SWISS RE N149.750.4%
- SWISSCOM N534.5-1.02%
- UBS GROUP N25.90.5%
- ZURICH INSURANCE N578.8-0.72%
- ABB LTD N45.420.82%
- ALCON N80.120.7%
- RICHEMONT N144.3-0.35%
- GEBERIT N593.41.3%
- GIVAUDAN N40190.5%
- HOLCIM N94.60.62%
- KUEHNE+NAGEL INT N179.65-2.26%
- LOGITECH N67.643.05%
- LONZA N576.20.88%
- NESTLE N87.610.63%
- NOVARTIS N91.450.37%
- PARTNERS GROUP N11151.5%
- ROCHE GS260.90.39%
- SIKA N208.51.07%
- SONOVA HOLDING AG253.50%
- SWISS LIFE HOLDING AG N840.80.12%
- SWISS RE N149.750.4%
- SWISSCOM N534.5-1.02%
- UBS GROUP N25.90.5%
- ZURICH INSURANCE N578.8-0.72%